Carcinoma in situ of the cervix, unspecified, refers to a localized, non-invasive form of cervical cancer characterized by abnormal cells confined to the epithelial layer of the cervix. This condition is primarily caused by persistent infection with high-risk human papillomavirus (HPV). Accurate coding with ICD-10 Code D06.9 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and follow-up.
ICD-10 Code D06.9 represents carcinoma in situ of the cervix, unspecified, indicating the presence of abnormal cells that have not invaded surrounding tissues. This code is used when the specific type of carcinoma in situ is not documented. It is crucial for clinical documentation and billing, particularly in cases where the diagnosis is confirmed but the subtype is not specified.
Carcinoma in situ of the cervix, unspecified, is a precancerous condition that requires prompt medical attention to prevent progression to invasive cervical cancer. The primary cause is often linked to high-risk HPV infections, which can lead to cellular changes in the cervix. Early detection through screening is vital for effective management.
ICD-10 Code D06.9 is utilized in SOAP notes to document the diagnosis of carcinoma in situ of the cervix, unspecified. It plays a critical role in capturing patient symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code D06.9 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of carcinoma in situ of the cervix, unspecified. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of carcinoma in situ of the cervix, unspecified, typically involves surgical intervention and close monitoring. Prompt treatment is crucial to prevent progression to invasive cancer.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D06.9 is critical in medical billing, particularly in hospital, ER, or gynecological care settings.
| CPT Code | Description |
|---|---|
| 88141 | Cytopathology, cervical or vaginal, screening, automated, with interpretation. |
| 57460 | Colposcopy of the cervix, with biopsy. |
| 57500 | Conization of cervix, with or without biopsy. |
Common Questions About Using ICD-10 Code D06.9 for Carcinoma in situ of cervix, unspecified
What are the risk factors for carcinoma in situ of the cervix?
Risk factors include persistent infection with high-risk HPV types, early sexual activity, multiple sexual partners, and smoking. Regular screening can help detect changes early.
How is carcinoma in situ of the cervix treated?
Treatment typically involves surgical procedures such as LEEP or cone biopsy to remove abnormal cells. Follow-up care is essential to monitor for recurrence.
Is carcinoma in situ of the cervix contagious?
Carcinoma in situ itself is not contagious; however, the underlying HPV infection can be transmitted through sexual contact. Vaccination can help prevent HPV infection.
What is the prognosis for carcinoma in situ of the cervix?
The prognosis is generally favorable with appropriate treatment. Early detection and management significantly reduce the risk of progression to invasive cervical cancer.
Clinical Notes
SOAP notes
DAP notes
AI medical notes